The Pediatric Cardiomyopathy Registry: 1995–2007

Grenier, 2000, Design and implementation of the North American Pediatric Cardiomyopathy Registry, Am Heart J, 139, S86, 10.1067/mhj.2000.103933 Towbin, 2006, Incidence, causes, and outcomes of dilated cardiomyopathy in children, Jama, 296, 1867, 10.1001/jama.296.15.1867 Lipshultz, 2003, The incidence of pediatric cardiomyopathy in two regions of the United States, N Engl J Med, 348, 1647, 10.1056/NEJMoa021715 Arola, 1997, Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland, Am J Epidemiol, 146, 385, 10.1093/oxfordjournals.aje.a009291 Nugent, 2003, The epidemiology of childhood cardiomyopathy in Australia, N Engl J Med, 348, 1639, 10.1056/NEJMoa021737 Colan, 2007, Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry, Circulation, 115, 773, 10.1161/CIRCULATIONAHA.106.621185 Cox, 2006, Factors associated with establishing a causal diagnosis for children with cardiomyopathy, Pediatrics, 118, 1519, 10.1542/peds.2006-0163 Kelley, 1991, X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria, J Pediatr, 119, 738, 10.1016/S0022-3476(05)80289-6 Bione, 1996, A novel X-linked gene, G4.5, is responsible for Barth syndrome, Nat Genet, 12, 385, 10.1038/ng0496-385 Schlame, 2002, Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome, Ann Neurol, 51, 634, 10.1002/ana.10176